EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitNetzwerk-MetaanalyseOpen Access · CC BY-NC-ND 4.0

First‐choice hormonal therapies for children with infantile epileptic spasms syndrome in South Asia: A network meta‐analysis of randomized controlled trials

Nagita Devi, Priyanka Madaan, Nidhun Kandoth, Parth Lal, Jitendra Kumar Sahu iD, Dipika Bansal iD

Epilepsia Open · 2024

DOI: 10.1002/epi4.13086 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epilepsia Open, 2024. Verfasst von Nagita Devi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Mohali, Punjab, India. Hauptthemen laut MEDLINE: Spasms, Infantile, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Considering the peculiar challenges with infantile epileptic spasms syndrome (IESS) in South Asia and a wide variation in the usage of hormonal therapies, we compared the efficacy and safety of various hormonal therapies for children with IESS in South Asia. We searched PubMed, Embase, Scopus, and Web of Science databases from the inception until April 2024. We included only randomized clinical trials (RCTs) evaluating the efficacy and safety of hormonal therapies for IESS in the South Asian region. Complete cessation of epileptic spasms (ES), electro‐clinical response, and time taken to be spasm‐free at 2 or 6 weeks of therapy were efficacy outcomes, while the occurrence of adverse events was the safety outcome. Effect estimates were reported as odds ratio (OR) or mean difference (MD) with 95% confidence intervals (CI) and Cochrane risk of bias 2.0 (ROB 2.0) used for quality assessment of each study. The surface under the cumulative ranking curve (SUCRA) was used to rank the different therapies and reported as a p ‐score ranging from 0 to 1. Of 747 citations, nine RCTs comprising 566 children with IESS were included. After 2‐week treatment, dexamethasone (OR: 6.72; 95% CI: 1.47, 30.72), adrenocorticotropic hormone therapy (ACTH) high dose (HD) (OR: 5.30; 95% CI: 1.05, 26.91), and prednisolone HD (OR: 2.41; 95% CI:1.07, 5.46) had shown significantly greater efficacy for cessation of EScompared with ACTH low dose (LD). Similarly, for electroclinical response, dexamethasone (OR: 9.63; 95% CI: 1.99, 46.70) and prednisolone HD (OR: 3.46; 95% CI: 1.38, 8.68) had greater efficacy compared with ACTH LD. Safety outcomes revealed that hypertension was significantly less common with ACTH LD and prednisolone HD as compared with ACTH HD. This study provides quality evidence on preferred first‐choice hormonal therapy for managing IESS in South Asia. ACTH HD, dexamethasone, and prednisolone HD are the most effective hormonal therapy options with dose‐dependent therapeutic efficacy. Plain Language Summary This study provides insights into the selection of first‐line hormonal therapies among the various treatments for managing infantile epileptic spasms syndrome (IESS) in South Asia. The study findings suggested that the effectiveness of these therapies is dose‐dependent, with high doses of ACTH, dexamethasone, and prednisolone being the most effective for achieving cessation of epileptic spasms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spasms, InfantileRandomized Controlled Trials as TopicHumansInfantAdrenocorticotropic HormoneDexamethasonePrednisoloneAsiaAnticonvulsantsChildTreatment OutcomeAsia, Southern

Stichwörter der Autor:innen

ACTHepileptic spasmsinfantile spasmswest syndrome

Substanzen

Adrenocorticotropic HormoneDexamethasonePrednisoloneAnticonvulsants

Autor:innen und Institutionen

  • Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Mohali, Punjab, India.
  • Department of Pharmacy Practice, Chandigarh College of Pharmacy, Landran, Punjab, India.
  • Department of Pediatric Neurology, Amrita School of Medicine, Amrita Vishwavidyapeetham, Faridabad, India.
  • Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

ORCID-Profile: Jitendra Kumar Sahu, Dipika Bansal

Zitieren

APA

Devi, N., Madaan, P., Kandoth, N., Lal, P., Sahu, J. K., & Bansal, D. (2024). First‐choice hormonal therapies for children with infantile epileptic spasms syndrome in South Asia: A network meta‐analysis of randomized controlled trials. Epilepsia Open. https://doi.org/10.1002/epi4.13086

Vancouver

Devi N, Madaan P, Kandoth N, Lal P, Sahu JK, Bansal D. First‐choice hormonal therapies for children with infantile epileptic spasms syndrome in South Asia: A network meta‐analysis of randomized controlled trials. Epilepsia Open. 2024. doi:10.1002/epi4.13086

BibTeX
@article{Devi2024,
  author = {Devi, Nagita and Madaan, Priyanka and Kandoth, Nidhun and Lal, Parth and Sahu, Jitendra Kumar and Bansal, Dipika},
  title = {First‐choice hormonal therapies for children with infantile epileptic spasms syndrome in South Asia: A network meta‐analysis of randomized controlled trials},
  journal = {Epilepsia Open},
  year = {2024},
  doi = {10.1002/epi4.13086}
}
Kostenlos starten →